Fears of a resurgence of Covid-19 infections have been compounded by possibilities of a global outbreak of monkeypox – a viral zoonotic disease with symptoms that include fever, rash, and swollen lymph nodes.
The disease that occurs primarily in tropical rainforest areas of Central and West Africa – occasionally exported to other regions – may lead to a range of medical complications.
This week, the Centre for Disease Control expressed concern about an unusual outbreak of monkeypox in the UK after seven cases were confirmed.
The UK reported its first case of monkeypox in a man arriving from Africa earlier this month, on 10 May.
Three days later the WHO said: “Based on currently available information, infection seems to have been locally acquired in the United Kingdom.”
With heightened fears of a global outbreak, the U.S. has ordered millions of smallpox vaccines.
Aljazeera reports that Africa’s top public health agency says several outbreaks of monkeypox on the continent have been contained during the Covid pandemic while the world’s attention was elsewhere.
“In a weekly news briefing on Wednesday, Ahmed Ogwell Ouma, acting director of the Africa Centre for Disease Control and Prevention, said outbreaks had been seen in the Democratic Republic of Congo, Nigeria, Cameroon and the Central African Republic,” reports Aljazeera.
Further cases have been identified in Spain, Portugal and the U.S.
Commenting on the outbreak on Friday, Dr. Eleanor Gaunt, a virologist and Research Fellow at the Roslin Institute, Edinburgh University said “we shouldn’t worry”.
Dr. Gaunt said for monkeypox to transmit from one person to another, “you must be in close contact with an infected person, and usually are exposed to their body fluids”.
In South Africa, the department of health is yet to publicly comment on the monkeypox outbreak.


